reSurge

Randomized Trial on Surgery for Glioblastoma Recurrence

Information

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

learn more

Community

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

learn more

Patients

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

learn more

Documents

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

learn more

Background

Patients with glioblastoma face a grim prognosis. Despite recent advancement in neurosurgical technology and neuro-oncology glioblastomas almost invariably progress or recur.

learn more about the trial

Objectives

The primary objective of this trial is to compare survival outcome after surgery followed by adjuvant second-line therapy to no surgery followed by second-line therapy in recurrent glioblastoma.

learn more about the trial

Latest News

Keep track on the Trial process

Thank you!

The ReSurge trial could achieve an increasing recruitment rate during the last year. This is great, especially in view of the pandemia which accompanies us for over a year now.[…]

Read more
February 1, 2021 0

New patients in

Also the newly opened sites in Larisa, Erfurt and Mainz could recuit their first patient. Moreover, one more patient was recruited in Lausanne and six in Bern.In total 36 patients[…]

Read more
December 10, 2019 0

First site in the Netherlands is recruiting

We very welcome Universitair Medische Centra in Amsterdam with their principal investigator Dr. Philip de Witt Hamer to the ReSurge trial team. Not long after recruitment start, the first patient[…]

Read more
December 10, 2019 0